In April 2019, the first case was reported of what quickly became a high number of lung damage cases that appeared to be linked to the use of e-cigarettes in the USA. By now over 2000 cases have been reported, including 34 deaths, and the condition has been given a name: “e-cigarette or vaping product use associated lung injury” (EVALI). All cases have been reported in the US and the CDC, FDA and state health authorities have been conducting investigations into causes. The latest advice based on those investigations is that it seems that EVALI is linked to street-bought tetrahydrocannabinol (THC) vaping, with vitamin E acetate, used as a cutting agent, implicated. It appears that nicotine vaping is not associated with EVALI.
This presentation will provide an overview of the EVALI “outbreak”, placing it in the context of the research evidence of the safety of nicotine vaping, the communications and media reporting used to inform the public about EVALI, and the potential consequences of misinformation.
Presenter: Prof Billie Bonevski, UON Women in Science Chair, Faculty of Health and Medicine, University of Newcastle
| WATCH THIS WEBINAR |
The effects of e-cigarette vaping on lung pathophysiology are slowly emerging which counter the unsupported claims of the nicotine/tobacco industry that electronic cigarettes are relatively safe. A single session of e-cigarette vaping has been shown to negatively affect lung function which is accentuated in asthmatics. Vaping has now also been linked to an increase in the risk of pneumonias, and in a mouse model e-cigarette vapour exposure has been shown to induce systemic inflammation and multi-organ fibrosis. This presentation will discuss the effects of electronic devices on lung health, supported by our own lab-based studies. This is important so that Australians are better informed when it comes to the safety of these newer devices and will help accelerate research efforts and allow health agencies to take evidence based regulatory decisions.
Presenter: Dr Sukhwinder Sohal, University of Tasmania, Launceston
| WATCH THIS WEBINAR |
In this webinar, we bring together our extensive research findings as well as world studies to provide an overview of what women are experiencing - what the evidence is saying – and where to from here, in order to reduce the harms of smoking among pregnant women. Hear from GP research fellow and Tobacco Treatment Specialist A/Prof Gillian Gould, and Dr Ratika Kumar a dentist specialising in smoking cessation research in high-priority populations.
Presenter: A/Prof Gillian Gould, and Ratika Kumar, University of NewcastleSmoking in pregnancy is a well-known risk factor for both maternal and child health in the short as well as long term. Considering the limited research in this area and the fact that more than half of the women who smoke are not able to give up smoking during pregnancy, harm minimisation (harm reduction) options are desired. Women report they receive mixed messages about quitting versus cutting down in pregnancy from their healthcare providers.
| WATCH THIS WEBINAR |
Deepali will look at the evidence for cardio vascular concerns vs benefits of medications used for smoking cessation with a focus also in patients with cardiac disease. Come for an open discussion to discuss your concerns in managing smoking cessation in a patient with cardiac disease.
Presenter: Deepali Gupta, Senior Pharmacist, Preventative Team PAH
| WATCH THIS WEBINAR |
Shared Medical Appointments (SMAs), or group consultations are: “… a series of individual office visits (billable at individual rates) sequentially attending to each patient’s unique medical needs individually, but in a supportive group setting where all can listen, interact, and learn.” SMAs have been successfully used in chronic diseases such as Obesity and Diabetes. This presentation will describe a project that engages GPs in smoking cessation and relapse prevention using the SMA model.
Presenters: Prof Garry Egger, Professor of Lifestyle Medicine, is well known for his Gut Busters series and his world leadership in Lifestyle Medicine and A/Prof Renee Bittoun, Founding Editor-in-Chief The Journal of Smoking Cessation, Cambridge University Press
| WATCH THIS WEBINAR |
Presenter: Dr Rodrigo Ramalho, Psychiatrist and Academic at the University of Auckland
| WATCH THIS WEBINAR |
Tanya is a medicinal chemist-turned-clinical researcher for the Airways Physiology and Imaging Group at the Woolcock Institute of Medical Research and Concord Hospital. Her area of research includes respiratory physiology in both Smoking and Asthma.
Presenter: Tanya Badal, Research Assistant, Woolcock Institute of Medical Research
| WATCH THIS WEBINAR |
January 2019 | Targeted and collective action on tobacco control leads to shifts in tobacco management and smoking cessation
| WATCH THIS WEBINAR |